Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach.

Journal of cancer research and therapeutics - 1 Jan 2000

Sipayya Varuna, Sharma Ira, Sharma K C, Singh Avninder

Abstract excerpt

BACKGROUND: Mutations in the gene encoding isocitrate dehydrogenase (IDH1) have been reported in gliomas. This study analyses a series of 184 glioma cases in a tissue microarray (TMA)-based approach to assess the frequency of R132H point mutations in formalin-fixed, paraffin-embedded tissue samples. MATERIALS AND METHODS: A total of 195 gliomas (30 pilocytic astrocytoma (PA), 45 diffuse astrocytoma [DA], 75...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to ErbB Receptors
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Immunohistochemistry

Share to Isocitrate Dehydrogenase

Share to Tissue Array Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 23361281
DOI: 10.4103/0973-1482.106567

Genes

IDH1
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach.PMID 23361281Read ↗

Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas.Semantic proximity Read ↗

Expanding the spectrum of IDH1 mutations in gliomas.Semantic proximity Read ↗

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.Semantic proximity Read ↗

Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.Semantic proximity Read ↗

IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.Semantic proximity Read ↗

Expression of mutated isocitrate dehydrogenase-1 in gliomas is associated with p53 and EGFR expression.Semantic proximity Read ↗

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma PatientsSemantic proximity Read ↗

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee.Semantic proximity Read ↗

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.Semantic proximity Read ↗

Isocitrate dehydrogenase mutations in defining the biology of and supporting clinical decision making in glioblastoma.Semantic proximity Read ↗

Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.Semantic proximity Read ↗

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.